This is a Validated Antibody Database (VAD) review about human FH, based on 4 published articles (read how Labome selects the articles), using FH antibody in all methods. It is aimed to help Labome visitors find the most suited FH antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
FH synonym: FMRD; HLRCC; LRCC; MCL; MCUL1; fumarate hydratase, mitochondrial; fumarase
Knockout validation
Cell Signaling Technology rabbit monoclonal (D9C5) |
| Cell Signaling Technology FH antibody (Cell Signaling, 4567) was used in western blot knockout validation on human samples at 1:1000 (fig 2b). Mol Cell Biol (2017) ncbi |
Santa Cruz Biotechnology
mouse monoclonal (J-13) |
| Santa Cruz Biotechnology FH antibody (Santa Cruz Biotechnology, sc-100743) was used in immunohistochemistry - paraffin section on human samples (fig 1). Am J Surg Pathol (2016) ncbi |
mouse monoclonal (J-13) |
| Santa Cruz Biotechnology FH antibody (Santa Cruz Biotechnology, sc-100743) was used in immunohistochemistry on human samples at 1:2000. Virchows Arch (2015) ncbi |
Cell Signaling Technology
rabbit monoclonal (D9C5) |
| Cell Signaling Technology FH antibody (CST, 4567) was used in western blot on human samples (fig 5a). Oncotarget (2017) ncbi |
rabbit monoclonal (D9C5) |
| Cell Signaling Technology FH antibody (Cell Signaling, 4567) was used in western blot knockout validation on human samples at 1:1000 (fig 2b). Mol Cell Biol (2017) ncbi |
Articles Reviewed
- MartÃnek P, Grossmann P, Hes O, Bouda J, Eret V, Frizzell N, et al. Genetic testing of leiomyoma tissue in women younger than 30 years old might provide an effective screening approach for the hereditary leiomyomatosis and renal cell cancer syndrome (HLRCC). Virchows Arch. 2015;467:185-91 pubmed publisher
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments